GAMMA Investing’s Inhibrx INBX Stock Holding History

GAMMA Investing’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$27.9K	Buy	279 +98	+54%	+$9.78K	﹤0.01%	2739
2026 Q2	$17.1K	Buy	181 +14	+8%	+$1.4K	﹤0.01%	2926
2026 Q1	$11.2K	Buy	167 +2	+1%	+$148	﹤0.01%	3009
2025 Q4	$13K	Buy	165 +26	+19%	+$1.77K	﹤0.01%	2848
2025 Q3	$4.68K	Sell	139 -16	-10%	-$394	﹤0.01%	3207
2025 Q2	$2.21K	Sell	155 -335	-68%	-$4.33K	﹤0.01%	3377
2025 Q1	$6.86K	Buy	490 +421	+610%	+$5.72K	﹤0.01%	2934
2024 Q4	$1.06K	Sell	69 -76	-52%	-$1.16K	﹤0.01%	3409
2024 Q3	$2.27K	Buy	145 +143	+7,150%	+$2.01K	﹤0.01%	3031
2024 Q2	$28	Buy	+2	New	+$31	﹤0.01%	3436

Other funds holding INBX

Persium Advisors Atlanta, Georgia $191M AUM 23.01% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

VCM

Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

GAMMA Investing's INBX Position: Q3 2026 in Review

GAMMA Investing increased its Inhibrx (INBX) stake by 54% in Q3 2026, buying an estimated $9.78K and bringing the position to 279 shares worth $27.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2739.

GAMMA Investing first reported a position in INBX in Q2 2024 and has held it in 10 quarters since. 5 funds tracked by Wall St. Rank hold INBX as of Q3 2026.

GAMMA Investing held 279 shares of Inhibrx worth $27.9K as of Q3 2026.
GAMMA Investing bought 98 Inhibrx shares in Q3 2026, an estimated $9.78K.
Inhibrx made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2739 holding.
GAMMA Investing first reported a position in Inhibrx in Q2 2024 and has held it in 10 quarters since.
5 funds tracked by Wall St. Rank held Inhibrx as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.